An unexpected finding after a fall from a horse.

The research article is about a case study where an initially presumed injury due to a horse fall turns out to be a condition related to an abnormally high white blood cell count in a 37-year-old jockey.

Abnormal Blood Count and Clinical Findings

• The jockey was admitted to the hospital after experiencing abdominal pain from a fall from a horse. However, the computed tomography scan showed an area of active bleeding within the spleen and a large underlying hematoma. Subsequent blood tests showed a significantly raised white blood cell count.
• Further analysis of the blood tests revealed a variety of immature myeloid cells, which were considered abnormal. The levels of his hemoglobin, mean cell volume, and platelets also differed from the reference range. In addition, the Lactate Dehydrogenase (LDH) levels and uric acid were elevated, which indicated a high turnover of bone marrow cells.
• The patient underwent a splenectomy due to these complications, and the removed spleen was larger than usual. Microscopic examination revealed a dense infiltrate of immature myeloid cells, confirming the abnormalities found in the blood tests.

Possible Causes and Diagnosis

• The significant rise in white blood cell count could be attributed to primary hematological diseases or a leukemoid reaction from a strong stimulus, like an infection, drug reaction, or underlying solid cancer.
• Nonetheless, a white cell count greater than 50×10^9 /L is usually linked to primary hematological cancer. In this case, the patient’s high count of immature myeloid cells – promyelocytes, myelocytes, metamyelocytes – suggests a strong possibility of a haematological disease leading to leucocytosis, or high white blood cell count.
• The persistent presence of these immature cells, which are typically found only in bone marrow, alongside the high uric acid and LDH levels, further supports this suspicion.

Further Investigation and Treatment Options

• Due to the unusual findings and suspicion of hematological disease, the researchers suggested the possibility of further related investigations.
• While the paper does not specify any treatments, the treatment options would most likely be tailored to tackling the hematological disease identified. The researchers imply that this could possibly include starting the patient on allopurinol (used for reducing uric acid levels) considering the raised uric acid levels detected in his system.